A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Human Immunodeficiency Virus (HIV) · HIV Pre-Exposure Prophylaxis

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • University of Alabama at Birmingham-UAB 1917 Research Clinic ( Site 0006), Birmingham, Alabama, United States

    Study coordinator · 205-934-2490
  • USA Health University Hospitals ( Site 0020), Mobile, Alabama, United States

    Study coordinator · 251-471-7000
  • UCLA Center for Clinical AIDS Research and Education ( Site 0004), Los Angeles, California, United States

    Study coordinator · 310-843-2015
  • Bridge HIV - San Francisco Department of Public Health ( Site 0001), San Francisco, California, United States

    Study coordinator · 628-217-7400
  • Whitman-Walker Institute ( Site 0016), Washington D.C., District of Columbia, United States

    Study coordinator · 202-207-2510
  • University of Miami RAPID Research ( Site 0003), Miami, Florida, United States

    Study coordinator · 305-243-4378
  • Orlando Immunology Center ( Site 0021), Orlando, Florida, United States

    Study coordinator · 407-374-0220
  • Hope Clinic of the Emory Vaccine Center ( Site 0009), Decatur, Georgia, United States

    Study coordinator · 404-712-1370
  • University of Illinois Chicago ( Site 0027), Chicago, Illinois, United States

    Study coordinator · 312-864-4578
  • University Medical Center New Orleans ( Site 0024), New Orleans, Louisiana, United States

    Study coordinator · 504-568-7740
  • Open Arms Healthcare Center ( Site 0025), Jackson, Mississippi, United States

    Study coordinator · 601-500-7660
  • Rutgers New Jersey Medical School ( Site 0010), Newark, New Jersey, United States

    Study coordinator · 848-445-4357
  • Montefiore Medical Center ( Site 0017), The Bronx, New York, United States

    Study coordinator · 718-920-2229
  • NC TraCS Institute - CTRC; University of North Carolina at Chapel Hill ( Site 0008), Chapel Hill, North Carolina, United States

    Study coordinator · 919-843-0720
  • Regional Center for Infectious Diseases ( Site 0018), Greensboro, North Carolina, United States

    Study coordinator · 336-832-3275
  • Philadelphia Fight Community Health Centers ( Site 0011), Philadelphia, Pennsylvania, United States

    Study coordinator · 214-985-4448
  • University of Pittsburgh Medical Center-Division of Infectious Diseases ( Site 0022), Pittsburgh, Pennsylvania, United States

    Study coordinator · 412-648-9636
  • Prisma Health Richland Hospital-Clinical Research Unit ( Site 0007), Columbia, South Carolina, United States

    Study coordinator · 803-434-7703
  • St. Jude Children's Research Hospital ( Site 0026), Memphis, Tennessee, United States

    Study coordinator · 901-595-3300
  • Meharry Medical College ( Site 0013), Nashville, Tennessee, United States

    Study coordinator · 615-327-6353
  • Central Texas Clinical Research ( Site 0014), Austin, Texas, United States

    Study coordinator · 512-496-9899
  • Saint Hope Foundation, Inc. ( Site 0015), Bellaire, Texas, United States

    Study coordinator · 713-839-7111
  • Fred Hutchinson Cancer Center - The Seattle HIV Vaccine Trials Unit ( Site 0002), Seattle, Washington, United States

    Study coordinator · 206-667-2300
  • Centro de Estudios Infectológicos S.A. ( Site 0357), CABA, Buenos Aires, Argentina

    Study coordinator · +5402920323936
  • Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada ( Site 0352), CABA, Buenos Aires, Argentina

  • Fundación Huésped ( Site 0350), CABA, Buenos Aires, Argentina

  • Instituto de Investigaciones Clínicas Mar del Plata ( Site 0353), Mar del Plata, Buenos Aires, Argentina

  • Fundación IDEAA ( Site 0351), Buenos Aires, Argentina

  • Fundaçao de Medicina Tropical Doutor Heitor Vieira Dourado ( Site 0412), Manaus, Amazonas, Brazil

    Study coordinator · +559221273589
  • Obras Sociais Irma Dulce ( Site 0406), Salvador, Estado de Bahia, Brazil

  • School of Medicine Federal University of Minas Gerais ( Site 0417), Belo Horizonte, Minas Gerais, Brazil

    Study coordinator · +5531984546856
  • Hospital Geral de Nova Iguacu ( Site 0411), Nova Iguaçu, Rio de Janeiro, Brazil

  • Ricardo Diaz Scientific Solutions ( Site 0402), São Paulo, São Paulo, Brazil

    Study coordinator · +5521997994412
  • Centro de Referência e Treinamento DST/AIDS ( Site 0400), São Paulo, São Paulo, Brazil

    Study coordinator · +551150879903
  • Hospital das Clinicas FMUSP ( Site 0401), São Paulo, São Paulo, Brazil

  • Instituto Nacional de Infectologia Evandro Chagas ( Site 0407), Rio de Janeiro, Brazil

    Study coordinator · +552138659595
  • Hospital Dr. Hernán Henríquez Aravena ( Site 0451), Temuco, Araucania, Chile

  • Universidad San Sebastian - Providencia ( Site 0454), Santiago, Region M. de Santiago, Chile

  • Universidad de Chile - Hospital Clínico Universidad de Chile-Inmunologia Alergia y VIH ( Site 0450), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56992280653
  • IPS SURA San Diego ( Site 0500), Medellín, Antioquia, Colombia

    Study coordinator · +57311728461
  • Clinica de la Costa S.A.S. ( Site 0501), Barranquilla, Atlántico, Colombia

    Study coordinator · +57 3128335766
  • Hospital Universitario San Ignacio ( Site 0503), Bogotá, Bogota D.C., Colombia

  • Fundación Valle del Lili ( Site 0502), Cali, Valle del Cauca Department, Colombia

    Study coordinator · 3164038861
  • CEMDOE - Centro Médico de Diabetes, Obesidad y Especialidades ( Site 1001), Santo Domingo, Nacional, Dominican Republic

  • Endocardio ( Site 1003), Santo Domingo, Nacional, Dominican Republic

  • Instituto Dermatológico y Cirugía de Piel "Dr. Huberto Bogaert Díaz" ( Site 1002), Santo Domingo de Guzman, Santo Domingo Province, Dominican Republic

  • Hopital Saint Louis ( Site 0100), Paris, France

  • Hôpital Tenon ( Site 0102), Paris, France

  • Hopital Bichat - Claude Bernard ( Site 0101), Paris, Île-de-France Region, France

  • Clínica Médica Especializada en Pediatría e Infectología Pediátrica - Dr. Mario Melgar ( Site 1051), Guatemala City, Guatemala

    Study coordinator · +50233911230
  • MEDI-K ( Site 1053), Guatemala City, Guatemala

    Study coordinator · +50222912323
  • CELAN,S.A ( Site 1052), Guatemala City, Guatemala

    Study coordinator · +5022912323
  • Partners for Health and Development in Africa ( Site 0201), Nairobi, Nairobi City, Kenya

    Study coordinator · +254733719711
  • Nyanza Reproductive Health Society ( Site 0200), Kisumu, Kenya

    Study coordinator · +25 474 073 5741
  • Impact Research and Development Organisation (IRDO) ( Site 0202), Kisumu, Kenya

    Study coordinator · +254722847249
  • Universiti Malaya Medical Centre ( Site 0651), Kuala Lumpur, Malaysia

    Study coordinator · +60379492351
  • Asociación Civil Selva Amazónica ( Site 0556), Iquitos, Loreto, Peru

    Study coordinator · 5165236277
  • Via Libre ( Site 0551), Lima, Peru

  • Policlínico Socios en Salud ( Site 0557), Lima, Peru

  • Investigaciones Medicas en Salud ( Site 0552), Lima, Peru

  • Asociación Civil Impacta Salud y Educación ( Site 0553), Lima, Peru

  • Universidad Nacional Mayor De San Marcos ( Site 0555), Lima, Peru

  • LoveYourself Inc. ( Site 0705), Mandaluyong, National Capital Region, Philippines

  • Philippine General Hospital ( Site 0700), Manila, National Capital Region, Philippines

  • Asian Hospital and Medical Center ( Site 0704), Muntinlupa, National Capital Region, Philippines

  • Foundation For Professional Development ( Site 0257), King Williams Town, Eastern Cape, South Africa

    Study coordinator · +27672388219
  • Wits RHI Research Center ( Site 0251), Johannesburg, Gauteng, South Africa

    Study coordinator · 011 358 5424
  • Setshaba Research Centre ( Site 0252), Pretoria, Gauteng, South Africa

    Study coordinator · 0127992422
  • Perinatal HIV Research Unit (PHRU) ( Site 0253), Soweto, Gauteng, South Africa

    Study coordinator · +27 11 989 9711
  • Wits Maternal Adolescent and Child Health Research Unit (WMRU) ( Site 0256), Durban, KwaZulu-Natal, South Africa

    Study coordinator · 031 001 1900
  • Desmond Tutu Health Foundation ( Site 0250), Cape Town, Western Cape, South Africa

    Study coordinator · +27216501941
  • University Hospital Basel ( Site 1102), Basel, Canton of Basel-City, Switzerland

    Study coordinator · +41612652525
  • Inselspital Bern ( Site 1103), Bern, Canton of Bern, Switzerland

    Study coordinator · +41316322111
  • Checkpoint Zurich ( Site 1100), Zurich, Switzerland

    Study coordinator · +41444555910
  • Chulalongkorn Hospital ( Site 0807), Bangkok, Bangkok, Thailand

    Study coordinator · +6622564930
  • HIV Netherlands Australia Thailand Research Collaboration ( Site 0808), Bangkok, Bangkok, Thailand

    Study coordinator · 086-045-1050
  • Institute of HIV Research and Innovation ( Site 0810), Bangkok, Bangkok, Thailand

    Study coordinator · +6621605371
  • Faculty of Medicine Siriraj Hospital ( Site 0806), Bangkok, Bangkok, Thailand

  • Research Institute for Health Sciences ( Site 0809), Muang, Chiang Mai, Thailand

    Study coordinator · +6653211363
  • Hanoi Medical University Hospital ( Site 0851), Hanoi, Hanoi, Vietnam

  • Thu Duc General Hospital ( Site 0881), Ho Chi Minh City, Vietnam

מובילי המחקר
  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC